Literature DB >> 16015355

Gleevec casts a pox on poxviruses.

Grant McFadden.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16015355     DOI: 10.1038/nm0705-711

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

2.  Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Authors:  Julie Dyall; Christopher M Coleman; Brit J Hart; Thiagarajan Venkataraman; Michael R Holbrook; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Peter B Jahrling; Monique Laidlaw; Lisa M Johansen; Calli M Lear-Rooney; Pamela J Glass; Lisa E Hensley; Matthew B Frieman
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

3.  Historical perspectives in the development of antiviral agents against poxviruses.

Authors:  Erik De Clercq
Journal:  Viruses       Date:  2010-06-14       Impact factor: 5.818

4.  Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

Authors:  Hari Krishna Ananthula; Scott Parker; Erin Touchette; R Mark Buller; Gopi Patel; Daniel Kalman; Johanna S Salzer; Nadia Gallardo-Romero; Victoria Olson; Inger K Damon; Tessa Moir-Savitz; Larry Sallans; Milton H Werner; Catherine M Sherwin; Pankaj B Desai
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-04       Impact factor: 2.483

Review 5.  Development of Small-Molecule MERS-CoV Inhibitors.

Authors:  Ruiying Liang; Lili Wang; Naru Zhang; Xiaoqian Deng; Meng Su; Yudan Su; Lanfang Hu; Chen He; Tianlei Ying; Shibo Jiang; Fei Yu
Journal:  Viruses       Date:  2018-12-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.